| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |